Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Hospitals that readmit 'too soon' will face Medicare penalty

Medicare soon will start docking payments to hospitals if they have a higher-than-expected level of patient readmissions within 30 days of being discharged.

4 Aug 2011

European Respiratory Journal publishes updated WHO guidelines on drug-resistant TB

The European Respiratory Journal is today publishing the updated guidelines of the World Health Organization (WHO) that aim to help manage drug-resistant tuberculosis.

4 Aug 2011

Avaxia receives BARDA contract to develop new radiation mitigation drug

Avaxia Biologics, Inc., a privately-held biotech company developing oral antibody drugs that act locally within the gastrointestinal tract, announced today it was awarded a contract with the Biomedical Advanced Research and Development Authority (BARDA), for the research and development of an oral antibody therapy to mitigate the gastrointestinal damage that follows radiation exposure that might occur after a nuclear incident.

4 Aug 2011

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

NanoBio Corporation today announced a licensing agreement with the National Institutes of Health (NIH) that represents a significant step forward in developing the first vaccine to protect against respiratory syncytial virus (RSV) infections.

4 Aug 2011

Viewpoints: Geithner, Bowles, Simpson, Ryan, Vladeck, Wilensky on health spending and the deficit

The agreement sets up a powerful mechanism for agreement on tax reforms to strengthen growth, and entitlement reforms to strengthen programs such as Medicare. A congressional committee with fast-track authority will have a Nov. 23 deadline to recommend a balanced package of long-term reforms to produce $1.5 trillion in additional deficit reduction.

4 Aug 2011

NanoViricides to apply 'lead optimization technology' to anti-HIV candidate

NanoViricides, Inc. recently reported on its completed animal study that compared its lead anti-HIV candidate HIVCide™, to a HAART (highly active anti retroviral therapy) triple drug cocktail. The cocktail used therein is based on an anti-HIV therapeutic protocol in current practice. The Company has received numerous inquiries for simplified explanation of the results.

3 Aug 2011

Study links indoor air cleaner use with improved asthma symptoms in children

A Johns Hopkins Children's Center study of Baltimore City children who have asthma and live with smokers shows that indoor air cleaners can greatly reduce household air pollution and lower the rates of daytime asthma symptoms to those achieved with certain anti-inflammatory asthma drugs.

3 Aug 2011

Needle-free nanopatch vaccine delivery system

The needle-free nanopatch vaccine delivery system is coming soon after a consortium of investors put up $15 million for its development. The money will enable University of Queensland's Professor Mark Kendall to continue his work on the technology. It is described as the biggest breakthrough in vaccine delivery since the invention of the syringe more than 150 years ago.

3 Aug 2011

Pfizer second-quarter revenues decrease 1% to $17.0 billion

Pfizer Inc. today reported financial results for second-quarter 2011. As a result of Pfizer's decision to sell the Capsugel business, all revenues and expenses related to Capsugel in all periods presented are reflected in a single line, Discontinued operations - net of tax.

3 Aug 2011

BARDA awards contracts for development of drugs for radiation injury to the GI tract

The first two contracts for advanced development of drugs to treat gastrointestinal (GI) tract injuries associated with acute radiation syndrome were awarded today by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA).

2 Aug 2011

New cold electron source could improve quality and speed of nanoimaging for drug development

A new source of very cold electrons will improve the quality and speed of nanoimaging for drug and materials development to a trillionth of a second.

2 Aug 2011

Antibody discovery leads researchers one step closer to universal influenza A vaccine

"The first human antibody that can knock out all influenza A viruses has been shown effective in lab mice, an exciting step forward in the hunt for a universal vaccine, researchers said Friday," Agence France-Presse reports.

2 Aug 2011

New liquid material shows promise for people with facial deformities

Biomedical engineers at Johns Hopkins have developed a new liquid material that in early experiments in rats and humans shows promise in restoring damaged soft tissue relatively safely and durably.

2 Aug 2011

Early life exposure to mold may increase risk of asthma in infants

Infants who live in "moldy" homes are three times more likely to develop asthma by age 7—an age that children can be accurately diagnosed with the condition.

2 Aug 2011

DHA during pregnancy prevents colds in babies: Study

A new study suggests that pregnant mothers who take DHA supplements with the intent of boosting their babies' brains are also giving them some added protection against common colds.

1 Aug 2011

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Cubist Pharmaceuticals, Inc. today announced the initiation of a pivotal Phase 3 trial of CXA-201 in patients with complicated urinary tract infections.

1 Aug 2011

Myb protein suppression can help eliminate acute myelogenous leukemia

A team of scientists at Cold Spring Harbor Laboratory (CSHL) has laid bare the mechanism behind a phenomenon called oncogene addiction in mice suffering from a form of leukemia that mimics acute myelogenous leukemia (AML) in humans.

1 Aug 2011

Three new loci linked to asthma susceptibility in Japanese population

Researchers at the RIKEN Center for Genomic Medicine (CGM), together with colleagues at Kyoto University, Tsukuba University, Harvard University, and other medical institutions have identified three new loci associated with susceptibility to adult asthma in the Japanese population.

1 Aug 2011

Universal flu vaccine based on “super antibody” coming soon

Researchers have finally found the first antibody which can fight all types of the influenza A virus. The results of the experiments on flu-infected mice, published in Science Express, showed the antibody could be used as an “emergency treatment” for flu as well.

31 Jul 2011

Therapeutic hypothermia might not be effective for children after heart attack

Intravenous delivery of cold fluids to reduce body temperature quickly after a heart attack and improve neurologic outcomes may not be as effective in children as it is in adults, according to a study reported in Therapeutic Hypothermia and Temperature Management, a peer-reviewed journal published by Mary Ann Liebert, Inc.

30 Jul 2011

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Hospitals that readmit 'too soon' will face Medicare penalty

European Respiratory Journal publishes updated WHO guidelines on drug-resistant TB

Avaxia receives BARDA contract to develop new radiation mitigation drug

NIH, NanoBio sign licensing agreement to develop vaccine against RSV infections

Viewpoints: Geithner, Bowles, Simpson, Ryan, Vladeck, Wilensky on health spending and the deficit

NanoViricides to apply 'lead optimization technology' to anti-HIV candidate

Study links indoor air cleaner use with improved asthma symptoms in children

Needle-free nanopatch vaccine delivery system

Pfizer second-quarter revenues decrease 1% to $17.0 billion

BARDA awards contracts for development of drugs for radiation injury to the GI tract

New cold electron source could improve quality and speed of nanoimaging for drug development

Antibody discovery leads researchers one step closer to universal influenza A vaccine

New liquid material shows promise for people with facial deformities

Early life exposure to mold may increase risk of asthma in infants

DHA during pregnancy prevents colds in babies: Study

Cubist initiates CXA-201 Phase 3 trial in complicated urinary tract infections

Myb protein suppression can help eliminate acute myelogenous leukemia

Three new loci linked to asthma susceptibility in Japanese population

Universal flu vaccine based on “super antibody” coming soon

Therapeutic hypothermia might not be effective for children after heart attack

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Pharmaceutical Manufacturing (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in